Steris (STE) Cash from Financing Activities (2018 - 2026)
Steris (STE) posted Cash from Financing Activities of -$213.5 million for Q2 2026, down 118.08% on a QoQ basis from -$97.9 million in Q1 2026, and little changed year-over-year from -$213.9 million in Q2 2025.
Analysis
Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Steris has reported Cash from Financing Activities for 9 years, with the latest figure at -$213.5 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities changed 0.19% year-over-year to -$213.5 million in Q2 2026; TTM through Jun 2026 was -$568.6 million, a 27.71% increase from a year earlier, with the FY2026 full-year figure at -$568.2 million, up 63.86% from the prior year.
- Cash from Financing Activities was -$213.5 million for Q2 2026 at Steris, down from -$97.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $470.2 million in Q3 2023, with the low at -$998.9 million in Q2 2024.
- Average Cash from Financing Activities over 5 years is -$178.5 million, with a median of -$179.5 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities jumped 1146.13% in 2023, then tumbled 367.57% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$120.4 million in 2022, then tumbled by 64.43% to -$198.0 million in 2023, then fell by 8.29% to -$214.4 million in 2024, then soared by 54.29% to -$98.0 million in 2025, then sank by 117.86% to -$213.5 million in 2026.
- The last three Cash from Financing Activities figures came in at -$213.5 million (Q2 2026), -$97.9 million (Q1 2026), and -$98.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -213.50 Mn |
| Mar 31, 2026 | -97.90 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Sep 30, 2025 | -159.20 Mn |
| Jun 30, 2025 | -213.10 Mn |
| Mar 31, 2025 | -178.10 Mn |
| Dec 31, 2024 | -214.40 Mn |
| Sep 30, 2024 | -181.00 Mn |
| Jun 30, 2024 | -998.90 Mn |
| Mar 31, 2024 | -143.78 Mn |
| Dec 31, 2023 | -197.99 Mn |
| Sep 30, 2023 | 470.21 Mn |
| Jun 30, 2023 | -213.64 Mn |
| Mar 31, 2023 | -191.95 Mn |
| Dec 31, 2022 | -120.41 Mn |
| Sep 30, 2022 | -44.95 Mn |
| Jun 30, 2022 | -141.41 Mn |
| Mar 31, 2022 | -274.61 Mn |
| Dec 31, 2021 | -189.27 Mn |
| Sep 30, 2021 | -239.11 Mn |